Annual EBITDA
$663.63 M
+$53.64 M+8.79%
December 31, 2023
Summary
- As of February 20, 2025, MRVI annual EBITDA is $663.63 million, with the most recent change of +$53.64 million (+8.79%) on December 31, 2023.
- During the last 3 years, MRVI annual EBITDA has risen by +$525.36 million (+379.94%).
- MRVI annual EBITDA is now at all-time high.
Performance
MRVI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$162.01 M
-$171.57 M-1794.84%
September 30, 2024
Summary
- As of February 20, 2025, MRVI quarterly EBITDA is -$162.01 million, with the most recent change of -$171.57 million (-1794.84%) on September 30, 2024.
- Over the past year, MRVI quarterly EBITDA has dropped by -$166.18 million (-3985.13%).
- MRVI quarterly EBITDA is now -123.67% below its all-time high of $684.57 million, reached on December 31, 2023.
Performance
MRVI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$534.32 M
-$166.18 M-23.72%
September 30, 2024
Summary
- As of February 20, 2025, MRVI TTM EBITDA is $534.32 million, with the most recent change of -$166.18 million (-23.72%) on September 30, 2024.
- Over the past year, MRVI TTM EBITDA has increased by +$390.39 million (+271.24%).
- MRVI TTM EBITDA is now -25.00% below its all-time high of $712.41 million, reached on December 31, 2023.
Performance
MRVI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MRVI EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.8% | -3985.1% | +271.2% |
| 3 y3 years | +379.9% | -3985.1% | +271.2% |
| 5 y5 years | +1896.0% | -3985.1% | +271.2% |
MRVI EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.6% | -123.7% | at low | -25.0% | +271.2% |
| 5 y | 5-year | at high | +1277.1% | -123.7% | at low | -25.0% | +6626.1% |
| alltime | all time | at high | +1896.0% | -123.7% | at low | -25.0% | +6626.1% |
Maravai LifeSciences Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$162.01 M(-1794.8%) | $534.32 M(-23.7%) |
| Jun 2024 | - | $9.56 M(+332.9%) | $700.50 M(+0.6%) |
| Mar 2024 | - | $2.21 M(-99.7%) | $696.40 M(-2.2%) |
| Dec 2023 | $663.63 M(+8.8%) | $684.57 M(>+9900.0%) | $712.41 M(+395.0%) |
| Sep 2023 | - | $4.17 M(-23.6%) | $143.93 M(-46.0%) |
| Jun 2023 | - | $5.46 M(-70.0%) | $266.57 M(-40.7%) |
| Mar 2023 | - | $18.22 M(-84.3%) | $449.44 M(-26.3%) |
| Dec 2022 | $609.99 M | $116.08 M(-8.5%) | $609.99 M(-6.8%) |
| Sep 2022 | - | $126.81 M(-32.7%) | $654.70 M(-5.7%) |
| Jun 2022 | - | $188.34 M(+5.4%) | $694.59 M(+3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $178.76 M(+11.2%) | $669.96 M(+12.7%) |
| Dec 2021 | $594.57 M(+330.0%) | $160.79 M(-3.5%) | $594.57 M(+28.3%) |
| Sep 2021 | - | $166.71 M(+1.8%) | $463.35 M(+32.7%) |
| Jun 2021 | - | $163.70 M(+58.4%) | $349.07 M(+74.5%) |
| Mar 2021 | - | $103.38 M(+249.6%) | $199.99 M(+44.6%) |
| Dec 2020 | $138.27 M(+186.9%) | $29.57 M(-43.6%) | $138.27 M(+18.5%) |
| Sep 2020 | - | $52.42 M(+258.7%) | $116.64 M(+81.6%) |
| Jun 2020 | - | $14.62 M(-64.9%) | $64.22 M(+29.5%) |
| Mar 2020 | - | $41.66 M(+424.4%) | $49.61 M(+524.4%) |
| Dec 2019 | $48.19 M(+44.9%) | $7.94 M | $7.94 M |
| Dec 2018 | $33.25 M | - | - |
FAQ
- What is Maravai LifeSciences Holdings annual EBITDA?
- What is the all time high annual EBITDA for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings annual EBITDA year-on-year change?
- What is Maravai LifeSciences Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings quarterly EBITDA year-on-year change?
- What is Maravai LifeSciences Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings TTM EBITDA year-on-year change?
What is Maravai LifeSciences Holdings annual EBITDA?
The current annual EBITDA of MRVI is $663.63 M
What is the all time high annual EBITDA for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high annual EBITDA is $663.63 M
What is Maravai LifeSciences Holdings annual EBITDA year-on-year change?
Over the past year, MRVI annual EBITDA has changed by +$53.64 M (+8.79%)
What is Maravai LifeSciences Holdings quarterly EBITDA?
The current quarterly EBITDA of MRVI is -$162.01 M
What is the all time high quarterly EBITDA for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high quarterly EBITDA is $684.57 M
What is Maravai LifeSciences Holdings quarterly EBITDA year-on-year change?
Over the past year, MRVI quarterly EBITDA has changed by -$166.18 M (-3985.13%)
What is Maravai LifeSciences Holdings TTM EBITDA?
The current TTM EBITDA of MRVI is $534.32 M
What is the all time high TTM EBITDA for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high TTM EBITDA is $712.41 M
What is Maravai LifeSciences Holdings TTM EBITDA year-on-year change?
Over the past year, MRVI TTM EBITDA has changed by +$390.39 M (+271.24%)